Do not use almotriptan malate and ergotamine within 24 hours of each other due to risk of prolonged vasospastic reactions.
Source: NLP:almotriptan malate
17 interactions on record
Do not use almotriptan malate and ergotamine within 24 hours of each other due to risk of prolonged vasospastic reactions.
Source: NLP:almotriptan malate
Ergotamine-containing drugs cause prolonged vasospastic reactions. Use within 24 hours of eletriptan hydrobromide is contraindicated due to additive effects.
Source: NLP:eletriptan hydrobromide
Co-administration associated with acute ergot toxicity characterized by vasospasm and ischemia of extremities and other tissues including central nervous system.
Source: NLP:erythromycin
Coadministration associated with acute ergot toxicity characterized by vasospasm and ischemia of extremities and central nervous system.
Source: NLP:erythromycin ethylsuccinate
Co-administration associated with acute ergot toxicity characterized by vasospasm and ischemia of central nervous system and tissues.
Source: NLP:erythromycin lactobionate
Coadministration is contraindicated. Itraconazole increases plasma concentrations of ergot alkaloids, potentially increasing pharmacologic effects and adverse reactions.
Source: NLP:itraconazole
Coadministration of ketoconazole with ergotamine is contraindicated.
Source: NLP:ketoconazole
Mifepristone increases ergotamine exposure; concomitant use is contraindicated due to narrow therapeutic range.
Source: NLP:mifepristone
Nitroglycerin markedly decreases first-pass metabolism of ergotamine, increasing bioavailability. Ergotamine can precipitate angina pectoris. Avoid concomitant use.
Source: NLP:nitroglycerin
Ergot-containing drugs cause prolonged vasospastic reactions. Use within 24 hours of rizatriptan benzoate is contraindicated due to potentially additive vasospastic effects.
Source: NLP:rizatriptan benzoate
Ergotamine-containing drugs cause prolonged vasospastic reactions that may be additive with sumatriptan. Use within 24 hours of each other is contraindicated.
Source: NLP:sumatriptan
Ergotamine-containing drugs cause prolonged vasospastic reactions; additive effects contraindicate use within 24 hours of sumatriptan succinate.
Source: NLP:sumatriptan succinate
Ergot-containing drugs cause prolonged vasospastic reactions. Coadministration within 24 hours is contraindicated due to additive effects.
Source: NLP:sumatriptan and naproxen sodium
Ergotamine-containing drugs cause prolonged vasospastic reactions that may be additive with zolmitriptan. Use within 24 hours of each other is contraindicated.
Source: NLP:zolmitriptan
Deferasirox may induce CYP3A4 resulting in decreased ergotamine concentration. Monitor for reduced effectiveness.
Source: NLP:deferasirox
Nitroglycerin decreases first-pass metabolism of ergotamine, increasing bioavailability. Ergotamine may precipitate angina pectoris; monitor or avoid concomitant use.
Source: NLP:nitroglycerin lingual
In vitro data of benzodiazepines suggest possible drug interaction with triazolam. Caution recommended.
Source: NLP:triazolam